(2S)-4-METHYLPENTAN-2-OL, 95%, 1g

2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole, 95.0%, 25g

1,1-Diethyl 3-oxocyclobutane-1,1-dicarboxylate, 95.0%, 25g

Periodic acid, min. 99%, for synthesis, 500 g, glass packaging

5-Bromo-3-nitro-1H-pyrazole, 98%, 1g

2-Methyl-3-oxobutanenitrile, 95.0%, 1g

(R)-(-)-4-Isopropyl-3-propionyl-2-oxazolidinone>98.0%(GC)5g

SODIUM BROMOACETATE, 95%, 25g

4-Methoxy-2-methylene-4-oxobutanoic acid, 95.0%, 100g

Dibenzyl 2-((R)-1-(((S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-2-hydroxymalonate, 95%, 100mg

1-(3-Bromo-phenyl)-2,2,2-trifluoro-ethylamine hydrochloride, 95.0%, 500mg

(3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)dihydrofuran-2(3H)-one, 98%, 1kg

2-[(3-methoxybenzyl)oxy]benzaldehyde, 95.0%, 5g